Some days back, I was online reading up stuff on Medscape and I came across a very interesting commentary. It was written by Dr. Sandra Fryhofer in relation to the current raging simvastatin saga and her review of the FDA's latest warnings about this popular statin. I am not going to pre-empt her. I share her thoughts here because I found them quite illuminating. Happy reading!
